Schizophrenia Trial, Recruiting (NCT05500001)

Schizophrenia Trial, Recruiting NCT05500001 Sponsor: University of Alberta Condition: Schizophrenia

Printed from Voxsanity (voxsanity.com.au) — NCT05500001 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Schizophrenia

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

The person is a young adult between 17 and 27 years old at the time of joining the trial
The person has been admitted to or discharged from a psychiatric unit for psychosis at Alberta Health Services or Covenant Health in the Edmonton Zone within the past 12 months

Who may not be able to join:

The person is not proficient in English
The person has not had an admission or discharge from an Alberta Health Services or Covenant Health psychiatric unit for psychosis in the Edmonton Zone within the past 12 months

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 21 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Melanie Robles, md, University of Alberta

Phone: (780) 983-9773

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05500001

Sponsor: University of Alberta

Phase: Not Applicable

Status: Recruiting

Condition: Schizophrenia

Trial contact: (780) 983-9773

More information: https://clinicaltrials.gov/study/NCT05500001

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

The person is a young adult between 17 and 27 years old at the time of joining the trial
The person has been admitted to or discharged from a psychiatric unit for psychosis at Alberta Health Services or Covenant Health in the Edmonton Zone within the past 12 months

Who may not be able to join:

The person is not proficient in English
The person has not had an admission or discharge from an Alberta Health Services or Covenant Health psychiatric unit for psychosis in the Edmonton Zone within the past 12 months

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 21 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Alberta

Registry

ClinicalTrials.gov

Start date

1 September 2022

Est. completion

1 September 2026

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Family Burden Interview Schedule; Family Burden Interview Schedule; Family Burden Interview Schedule; Family Burden Interview Schedule; Positive and Negative Symptom Schedule; Positive and Negative Symptom Schedule; Positive and Negative Symptom Schedule; Positive and Negative Symptom Schedule; Manchester Short Assessment of Quality of Life; Manchester Short Assessment of Quality of Life; Manchester Short Assessment of Quality of Life; Manchester Short Assessment of Quality of Life

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov